Stay updated on AbbVie Press Releases
Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest updates to the AbbVie Press Releases page
- ChecktodayChange DetectedAbbVie has received European Commission approval for SKYRIZI® to treat adults with moderately to severely active ulcerative colitis, while recent updates on executive appointments and regulatory news have been removed.SummaryDifference59%
- CheckyesterdayChange DetectedAbbVie has reported its second-quarter 2024 financial results, highlighting performance that exceeded expectations, while previous announcements regarding the earnings conference call and the 2022 ESG report have been removed.SummaryDifference52%
- Check2 days agoChange DetectedRecent updates include a focus on partnerships to eliminate hepatitis C by 2030, as highlighted by AbbVie, alongside a new initiative addressing the emotional impact of nighttime symptoms on Parkinson's disease patients and their care partners.SummaryDifference28%
- Check3 days agoChange DetectedThere have been recent additions to the website four days ago, while some content was removed just two days ago.SummaryDifference2%
- Check5 days agoChange DetectedNew content was added to the website three days ago, while some content was removed just a day ago.SummaryDifference2%
- Check6 days agoChange DetectedRecent updates include two new additions made two days ago, while some content was removed just 20 hours ago.SummaryDifference3%
Stay in the know with updates to AbbVie Press Releases
Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.